- Presentations
- 2
- Markets
- 1
Lorbrena is a brand of Lorlatinib marketed by Pfizer Laboratories, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Lorlatinib
- Brand owner
- Pfizer Laboratories
- Registered in
- United States
- Strengths and forms
- 100 mg tablet, 25 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Lorbrena 100 mg tabletOral | Pfizer Laboratories | US FDA | Available on request |
| Lorbrena 25 mg tabletOral | Pfizer Laboratories | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Lorbrena
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.